Kaseb, A.O.; Mohamed, Y.I.; Malek, A.E.; Raad, I.I.; Altameemi, L.; Li, D.; Kaseb, O.A.; Kaseb, S.A.; Selim, A.; Ma, Q.
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection. Pathogens 2021, 10, 379.
https://doi.org/10.3390/pathogens10030379
AMA Style
Kaseb AO, Mohamed YI, Malek AE, Raad II, Altameemi L, Li D, Kaseb OA, Kaseb SA, Selim A, Ma Q.
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection. Pathogens. 2021; 10(3):379.
https://doi.org/10.3390/pathogens10030379
Chicago/Turabian Style
Kaseb, Ahmed O., Yehia I. Mohamed, Alexandre E. Malek, Issam I. Raad, Lina Altameemi, Dan Li, Omar A. Kaseb, Safa A. Kaseb, Abdelhafez Selim, and Qing Ma.
2021. "The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection" Pathogens 10, no. 3: 379.
https://doi.org/10.3390/pathogens10030379
APA Style
Kaseb, A. O., Mohamed, Y. I., Malek, A. E., Raad, I. I., Altameemi, L., Li, D., Kaseb, O. A., Kaseb, S. A., Selim, A., & Ma, Q.
(2021). The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection. Pathogens, 10(3), 379.
https://doi.org/10.3390/pathogens10030379